Allowing additional time for U.S. and UK regulators to sign off on the merger, Roche (OTCQX:RHHBY) has extended its tender offer for all outstanding shares of Spark Therapeutics (NASDAQ:ONCE) to November 25. The previous expiration date was October 30.
Roche announced its $114.50/share bid in February.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.